Научно-практический журнал Медицинские технологии. Оценка и выбор
  • Русский
  • English

New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation

Issue № 32 | 2018 (2)

DOI: https://doi.org/10.31556/2219-0678.2018.32.2.008-022 meta

Abstract

The article explains the prerequisites, principles and steps of the developing in 2018 new diagnostic related groups (DRG) for inpatient cancer pharmacotherapy in Russian healthcare. New DRGs were developed in 5 steps: 1) most prevalent malignant tumors were revealed based on statistical data on the cancer incidence rate in 2016; 2) all recommended schemes of drug therapy for the most prevalent tumors were extracted from clinical guidelines made by Russian Oncology Association; 3) standards of medical care were created for the cases of hospital treatment with the use of each scheme of drug therapy; 4) the costs of hospital treatment with the use of each scheme were calculated; 5) cases with similar costs were combined into DRGs. 10 DRGs were formed for inpatient treatment and 8 – for treatment in the day hospitals. The cost-based relative weights were determined for each DRG. The system for coding drug regimens was developed for computerized assignment of cases to the DRGs in the Russian regions. The new DRGs are more homogeneous than previous ones in terms of clinical and economic characteristics, thus the main principle of DRG development is followed to a greater extent than before. Authors underline the necessity to monitor the results of the new DRGs implementation at the regions for minimizing the risks of imbalance in the payment system.

Keywords

provider-payment method in healthcare; diagnostic related group (DRG), cancer; standard of medical care; clinical guideline.

For citations

Avxentyeva M. V., Omelyanovskiy V. V., Petrovskiy A. V. et al. New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation. Medical Technologies. Assessment and Choice. 2018; 2(32): 8–22.

mt_32_2018-2_8-22